Blueprint Medicines
BPMC
#2370
Rank
C$8.90 B
Marketcap
$140.24
Share price
-0.55%
Change (1 day)
72.69%
Change (1 year)

Market capitalization of Blueprint Medicines (BPMC)

Market cap: C$8.90 Billion

As of November 2024 Blueprint Medicines has a market cap of C$8.90 Billion. This makes Blueprint Medicines the world's 2370th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Blueprint Medicines from 2015 to 2024

End of year Market Cap

Year Marketcap Change
2024C$8.90 B19.79%
2023C$7.43 B109.1%
2022C$3.55 B-55.72%
2021C$8.03 B0.78%
2020C$7.96 B54.59%
2019C$5.15 B59.41%
2018C$3.23 B-21.52%
2017C$4.12 B230.49%
2016C$1.24 B26.08%
2015C$0.98 B

End of Day market cap according to different sources

On Nov 10th, 2024 the market cap of Blueprint Medicines was reported to be:

C$8.90 Billion
by Yahoo Finance info icon info icon
C$8.90 Billion
by CompaniesMarketCap info icon info icon
C$8.90 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
C$0.14 B-98.33%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.46 B-83.58%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.87 B-90.21%๐Ÿ‡บ๐Ÿ‡ธ USA
C$15.20 B 70.66%๐Ÿ‡บ๐Ÿ‡ธ USA